Patrick McCall - 13 Dec 2023 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Financial Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 08:23:39 UTC
Previous filing
28 Aug 2023
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +20,492 +327% 26,755 13 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Award +20,492 20,492 13 Dec 2023 Common Stock 20,492 $1.25 Direct F1, F2
transaction INAB Series B Warrants (right to buy) Award +20,492 20,492 13 Dec 2023 Common Stock 20,492 $1.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.
F2 Fully vested and exercisable.